BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3523873)

  • 1. A monoclonal anti-C4d that demonstrates a specificity related to anti-Ch.
    Giles CM; Ford DS
    Transfusion; 1986; 26(4):370-4. PubMed ID: 3523873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic determinants of human C4, Rodgers and Chido.
    Giles CM
    Exp Clin Immunogenet; 1988; 5(2-3):99-114. PubMed ID: 2483343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three Chido determinants detected on the B5Rg+ allotype of human C4: their expression in Ch-typed donors and families.
    Giles CM
    Hum Immunol; 1987 Feb; 18(2):111-22. PubMed ID: 2435683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Partial inhibition' of anti-Rg and anti-Ch reagents. II. Demonstration of separable antibodies for different determinants.
    Giles CM
    Vox Sang; 1985; 48(3):167-73. PubMed ID: 2580392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro binding of C4 molecules on red cells: a correlation of numbers of molecules and agglutination.
    Giles CM; Davies KA; Walport MJ
    Transfusion; 1991; 31(3):222-8. PubMed ID: 1706118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rodgers (Rg) and Chido (Ch) determinants on human C4: characterization of two C4 B5 subtypes, one of which contains Rg and Ch determinants.
    Roos MH; Giles CM; Demant P; Mollenhauer E; Rittner C
    J Immunol; 1984 Nov; 133(5):2634-40. PubMed ID: 6207239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C4B3 allotype with a novel Ch phenotype.
    Skanes VM; Larsen B; Giles CM
    Immunogenetics; 1985; 22(6):609-16. PubMed ID: 3865894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rapid identification of Chido and Rodgers antibodies using C4d-coated red blood cells.
    Judd WJ; Kraemer K; Moulds JJ
    Transfusion; 1981; 21(2):189-92. PubMed ID: 7222201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic determinants expressed by human C4 allotypes; a study of 325 families provides evidence for the structural antigenic model.
    Giles CM; Uring-Lambert B; Goetz J; Hauptmann G; Fielder AH; Ollier W; Rittner C; Robson T
    Immunogenetics; 1988; 27(6):442-8. PubMed ID: 2453461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A structural model for the location of the Rodgers and the Chido antigenic determinants and their correlation with the human complement component C4A/C4B isotypes.
    Yu CY; Campbell RD; Porter RR
    Immunogenetics; 1988; 27(6):399-405. PubMed ID: 2453459
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-C4 in the serum of a transfused C4-deficient patient with systemic lupus erythematosus.
    Giles CM; Swanson JL
    Vox Sang; 1984; 46(5):291-9. PubMed ID: 6730425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism of the fourth component of human complement: population study and proposal for a revised nomenclature based on genomic PCR typing of Rodgers and Chido determinants.
    Schneider PM; Stradmann-Bellinghausen B; Rittner C
    Eur J Immunogenet; 1996 Oct; 23(5):335-44. PubMed ID: 8909940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two monoclonal anti-C4d reagents react with epitopes closely related to Rg:1 and Ch:1.
    Giles CM; Fielder AH; Lord DK; Robson T; O'Neill GJ
    Immunogenetics; 1987; 26(4-5):309-12. PubMed ID: 2443448
    [No Abstract]   [Full Text] [Related]  

  • 14. Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity.
    Yu CY; Belt KT; Giles CM; Campbell RD; Porter RR
    EMBO J; 1986 Nov; 5(11):2873-81. PubMed ID: 2431902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antipeptide antibodies against amino acid residues 1101-1106 of human C4 distinguish C4A from C4B.
    Reilly BD; Levine P; Rothbard J; Skanes VM
    Complement Inflamm; 1991; 8(1):33-42. PubMed ID: 2049934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive RFLPs to distinguish between the human complement C4A/C4B isotypes and the major Rodgers/Chido determinants: application to the study of C4 null alleles.
    Yu CY; Campbell RD
    Immunogenetics; 1987; 25(6):383-90. PubMed ID: 2439447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the Chido/Rodgers blood group system.
    Mougey R
    Immunohematology; 2019 Dec; 35(4):135-138. PubMed ID: 31935328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA haplotypes with C4B5; evidence for further allelic heterogeneity.
    Hing SN; Giles CM; Fielder AH; Batchelor JR
    Immunogenetics; 1986; 23(3):151-5. PubMed ID: 3485571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An international reference typing for Ch and Rg determinants on rare human C4 allotypes.
    Rittner C; Tippett P; Giles CM; Mollenhauer E; Berger R; Nordhagen R; Buskjaer L; Bruun-Petersen G; Lamm L; Roos MH
    Vox Sang; 1984; 46(4):224-34. PubMed ID: 6201005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chido, Rodgers and C4. In vivo and in vitro coating of red blood cells, grouping and antibody detection.
    Nordhagen R; Heier Larsen AM; Beckers D
    Vox Sang; 1979; 37(3):170-8. PubMed ID: 91269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.